Pages that link to "Q80204825"
Jump to navigation
Jump to search
The following pages link to Intradermal/subcutaneous immunization by electroporation improves plasmid vaccine delivery and potency in pigs and rhesus macaques (Q80204825):
Displaying 50 items.
- Comparative ability of IL-12 and IL-28B to regulate Treg populations and enhance adaptive cellular immunity (Q24642027) (← links)
- Synthetic DNA vaccine strategies against persistent viral infections (Q27016078) (← links)
- Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus (Q27487330) (← links)
- Vaccines: the Fourth Century (Q27490454) (← links)
- Amiloride enhances antigen specific CTL by faciliting HBV DNA vaccine entry into cells (Q28481556) (← links)
- Evaluation of a novel non-penetrating electrode for use in DNA vaccination (Q28740588) (← links)
- Protective immunity to H7N9 influenza viruses elicited by synthetic DNA vaccine. (Q30360232) (← links)
- Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. (Q30372481) (← links)
- An Enhanced Synthetic Multiclade DNA Prime Induces Improved Cross-Clade-Reactive Functional Antibodies when Combined with an Adjuvanted Protein Boost in Nonhuman Primates. (Q30375785) (← links)
- Obstacles to the successful development of an efficacious T cell-inducing HIV-1 vaccine. (Q30378897) (← links)
- Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. (Q30395101) (← links)
- Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review (Q30404393) (← links)
- Influenza A vaccines using linear expression cassettes delivered via electroporation afford full protection against challenge in a mouse model (Q30414135) (← links)
- Fusion of antigen to a dendritic cell targeting chemokine combined with adjuvant yields a malaria DNA vaccine with enhanced protective capabilities (Q31152863) (← links)
- Heterosubtypic protection against pathogenic human and avian influenza viruses via in vivo electroporation of synthetic consensus DNA antigens (Q33346277) (← links)
- Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment (Q33507532) (← links)
- Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation (Q33555860) (← links)
- Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device (Q33586294) (← links)
- Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments (Q33713435) (← links)
- Optimization of intradermal vaccination by DNA tattooing in human skin (Q33792008) (← links)
- Electroporation as a vaccine delivery system and a natural adjuvant to intradermal administration of plasmid DNA in macaques (Q33829920) (← links)
- DNA immunization of Mycobacterium tuberculosis resuscitation-promoting factor B elicits polyfunctional CD8(+) T cell responses (Q33850516) (← links)
- Variable epitope libraries: new vaccine immunogens capable of inducing broad human immunodeficiency virus type 1-neutralizing antibody response (Q33907538) (← links)
- High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model (Q33987553) (← links)
- Transfection by electroporation (Q34748879) (← links)
- In vivo electroporation of constitutively expressed HIF-1α plasmid DNA improves neovascularization in a mouse model of limb ischemia. (Q34816608) (← links)
- DNA vaccines: ready for prime time? (Q34824179) (← links)
- Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array. (Q34977670) (← links)
- Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses (Q35049821) (← links)
- Optimization of a plasma facilitated DNA delivery method (Q35138037) (← links)
- DNA vaccines in veterinary use. (Q35586830) (← links)
- HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial (Q35677513) (← links)
- Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine (Q35771272) (← links)
- Cellular immunity induced by a novel HPV18 DNA vaccine encoding an E6/E7 fusion consensus protein in mice and rhesus macaques (Q35771342) (← links)
- Technologies for enhanced efficacy of DNA vaccines (Q35802958) (← links)
- Elucidating the Kinetics of Expression and Immune Cell Infiltration Resulting from Plasmid Gene Delivery Enhanced by Surface Dermal Electroporation (Q35826661) (← links)
- Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation. (Q35826698) (← links)
- Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity (Q35826774) (← links)
- Optimized in vivo transfer of small interfering RNA targeting dermal tissue using in vivo surface electroporation. (Q36053828) (← links)
- Noninvasive Transdermal Vaccination Using Hyaluronan Nanocarriers and Laser Adjuvant (Q36189410) (← links)
- Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses. (Q36228884) (← links)
- A combination of intradermal jet-injection and electroporation overcomes in vivo dose restriction of DNA vaccines (Q36494079) (← links)
- Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business". (Q36498186) (← links)
- IL-4 and IFN-γ induced by human immunodeficiency virus vaccine in a schistosome infection model (Q36694816) (← links)
- Nonstructural protein 2 (nsP2) of Chikungunya virus (CHIKV) enhances protective immunity mediated by a CHIKV envelope protein expressing DNA Vaccine (Q36837548) (← links)
- Synthetic DNA immunogen encoding hepatitis B core antigen drives immune response in liver (Q36871557) (← links)
- Comparison of electrically mediated and liposome-complexed plasmid DNA delivery to the skin (Q37074321) (← links)
- Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus (Q37157152) (← links)
- Inducing humoral and cellular responses to multiple sporozoite and liver-stage malaria antigens using exogenous plasmid DNA. (Q37264722) (← links)
- Synthetic DNA vaccines: improved vaccine potency by electroporation and co-delivered genetic adjuvants. (Q37276912) (← links)